Multi-Pronged Alliqua, Inc. (ALQA) Builds Intellectual Property Portfolio
Many biotechnology firms are focused on developing new drug delivery platforms. There are many reasons and several different methodologies biotechs large and small use to replace the conventional approaches of oral and injectable delivery methods. Some “heavy hitting” reasons for the quest are to reduce stress on the liver and to improve patient compliance. Alliqua, Inc., a New York based advanced biomedical products company, is committed to the development and manufacturing of proprietary drug delivery with an emphasis on a transdermal platform. For those unaware, “transdermal” is exactly what it sounds like; drugs delivered through the skin. Most of the…
